Anjali Pandya
- Pharmaceutical Science top 5%
- Advancements in Transdermal Drug Delivery 6
- Advanced Drug Delivery Systems 5
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research 3
-
- Lipid Membrane Structure and Behavior 4
-
- Cerebrovascular and Carotid Artery Diseases 3
-
- Cardiovascular Health and Disease Prevention 3
-
- Pharmacological Effects and Toxicity Studies 2
-
- Acute Ischemic Stroke Management 2
- Co-authors
- Vandana PatravaleLalitkumar K. VoraVivek P. ChavdaYanhong DuoBen Zhong TangSalwaLalit KumarNidhi Raval
- Partner nations
- IndiaUnited KingdomCanada
In The Last Decade
Anjali Pandya
24 papers receiving 502 citations
Peers
Comparison fields: 5 of 105
- Pharmaceutical Science 119
- Infectious Diseases 131
- Molecular Medicine 21
- Biomaterials 52
- Dermatology 27
Countries citing papers authored by Anjali Pandya
This map shows the geographic impact of Anjali Pandya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anjali Pandya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anjali Pandya more than expected).
Fields of papers citing papers by Anjali Pandya
This network shows the impact of papers produced by Anjali Pandya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anjali Pandya. The network helps show where Anjali Pandya may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Anjali Pandya, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 9 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 5 | |
| 7 | 2023 | 47 | |
| 8 | 2023 | 39 | |
| 9 | 2022 | 5 | |
| 10 | 2022 | 14 | |
| 11 | 2022 | 56 | |
| 12 | 2022 | 1 | |
| 13 | 2021 | 16 | |
| 14 | 2021 | 147 | |
| 15 | 2021 | 6 | |
| 16 | 2021 | 6 | |
| 17 | 2020 | 7 | |
| 18 | 2018 | 4 | |
| 19 | 2011 | 2 | |
| 20 | 2010 | 2 |
About Anjali Pandya
Anjali Pandya is a scholar working on Pharmaceutical Science, Microbiology and Infectious Diseases, having authored 27 papers that have together received 505 indexed citations. Recurring topics across this work include Advancements in Transdermal Drug Delivery (6 papers), Advanced Drug Delivery Systems (5 papers), Lipid Membrane Structure and Behavior (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Cerebrovascular and Carotid Artery Diseases (3 papers), Cardiovascular Health and Disease Prevention (3 papers), Pharmacological Effects and Toxicity Studies (2 papers) and Acute Ischemic Stroke Management (2 papers). The work is most often cited by research in Pharmaceutical Science (119 citations), Infectious Diseases (131 citations) and Molecular Medicine (21 citations). Anjali Pandya has collaborated with scholars based in India, United Kingdom and Canada. Frequent co-authors include Vandana Patravale, Lalitkumar K. Vora, Vivek P. Chavda, Yanhong Duo, Ben Zhong Tang, Salwa, Lalit Kumar, Nidhi Raval, Vidhi Shah and Chukwuebuka Emmanuel Umeyor.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.